• Electroporation for CRISPR Editing in Mouse Zygotes

  2026-09-22

  Hashimoto and Takemoto showed that electroporation can deliver CRISPR/Cas9 RNA into mouse zygotes with an intact zona pellucida, providing a scalable alternative to embryo microinjection. Their optimized pulse conditions supported both nuclease-mediated mutation and ssODN-directed knock-in, although the findings remain specific to early mouse embryos and require careful optimization in other systems.

• Staurosporine A8192: Reliable Apoptosis Assays

  2026-09-22

  This scenario-based guide explains how Staurosporine (SKU A8192) can support reproducible apoptosis, viability, and kinase-signaling experiments while addressing solubility, dosing, and interpretation challenges. It connects product-specific handling data with practical controls and literature-based guidance for separating cell death from assay artifacts.

• Palonosetron hydrochloride in 5-HT3 Assays

  2026-09-21

  Palonosetron hydrochloride supports precise nanomolar 5-HT3A and 5-HT3AB receptor studies, while its micromolar activity enables a separate OCT2 and MATE1 renal transporter workflow. This guide translates pharmacology into practical cell-based assays, controls, troubleshooting steps, and cancer research applications.

• DPPH Workflow for In Vitro Antioxidant Screening

  2026-09-21

  DPPH provides a fast, plate-compatible way to rank purified compounds, extracts, and cultivation conditions by radical-scavenging activity. This workflow pairs fresh reagent preparation and matrix controls with orthogonal profiling, helping researchers distinguish useful antioxidant hits from color or solubility artifacts.

• Cas9 mRNA Design for Translational Editing

  2026-09-20

  A mechanistic and strategic guide to using Cap1-capped, m1Ψ-modified Cas9 mRNA for reproducible CRISPR-Cas9 genome editing in mammalian systems, with evidence-based lessons from electroporation in mouse zygotes.

• Type III Collagen Restricts Breast Cancer Progression

  2026-09-19

  This study identifies type III collagen (Col3) as a tumor-restrictive component of the breast cancer microenvironment. By combining fibroblast-derived matrices, patient tissue analysis, TCGA bioinformatics, 3D cultures, and mouse models, the authors show that increased Col3 relative to type I collagen is associated with less aggressive disease and reduced tumor growth and metastasis.

• Z-VAD-FMK in Necroptosis Assay Design

  2026-09-18

  Z-VAD-FMK is more than an apoptosis inhibitor: it can serve as a causal probe for separating caspase-dependent death from necroptosis. This article translates recent hepatic stellate cell findings into practical assay decisions, controls, and interpretation strategies.

• Electroporation Enables CRISPR Editing in Mouse Zygotes

  2026-09-18

  Hashimoto and Takemoto showed that electroporation can deliver Cas9 mRNA and guide RNA into mouse zygotes without removing the zona pellucida, providing a scalable alternative to embryo microinjection. Their optimized workflow supported both Fgf10 disruption and ssODN-mediated knock-in, while linking pulse intensity and embryo survival to practical protocol design.

• Neticonazole Hydrochloride: Research Workflows

  2026-09-17

  Neticonazole Hydrochloride supports two complementary research tracks: validated topical antifungal workflows and exploratory colorectal cancer studies focused on exosome inhibition and apoptosis. This guide converts diagnostic evidence into practical assay design, formulation, controls, and troubleshooting steps.

• Notch Blockade Sensitizes TNBC to Checkpoint Therapy

  2026-09-17

  Shen et al. show that suppressing Notch-dependent cytokine programs can remodel the tumor immune microenvironment and improve sequential immune checkpoint blockade in triple-negative breast cancer. The work links tumor-cell signaling to macrophage recruitment, cytotoxic T-cell activation, and suppression of lung metastasis, providing a mechanistic framework for combination immunotherapy studies.

• EZ Cap™ Cas9 mRNA (m1Ψ) for Precise Editing

  2026-09-16

  EZ Cap™ Cas9 mRNA (m1Ψ) combines Cap1 capping, m1Ψ modification, and a poly(A) tail for transient Cas9 expression in mammalian-cell editing workflows. This guide translates those design features into practical delivery, assay-selection, troubleshooting, and nuclear-export control strategies.

• Predictive siRNA Codelivery with Netarsudil

  2026-09-16

  Slaughter and colleagues developed a quantitative workflow for predicting whether ionizable drugs can complex siRNA and support co-encapsulation in lipid-like nanoparticles. Netarsudil emerged as a high-performing candidate and, in fibrotic human trabecular meshwork cells, enabled CTGF-targeting siRNA delivery associated with reduced CTGF mRNA and actin network density.

• Hoechst 33342 for Senescence Imaging Workflows

  2026-09-15

  Hoechst 33342 supports consistent nuclear segmentation in live and fixed human dermal fibroblast assays, helping connect cell counts and morphology with mitochondrial-quality measurements. This workflow shows how to use the dye as a quantitative imaging and flow-cytometry reference without mistaking nuclear labeling for a standalone senescence marker.

• EGCG: Mechanisms, Evidence, and Research Workflow

  2026-09-15

  (-)-Epigallocatechin gallate (EGCG) is a green tea catechin used in apoptosis assay, antiviral research, cancer chemoprevention, and biomaterial studies. Evidence supports pathway-level activity, while the strongest recent intervertebral disc evidence concerns an EGCG-containing hydrogel microsphere rather than free EGCG monotherapy.

• YC-1 in Neuroinflammation Assay Design

  2026-09-14

  Explore how YC-1 can function as a mechanistic control in hypoxia and cancer research while clarifying what a recent trigeminal neuralgia study does—and does not—establish. This article translates the study’s Ca2+-CGRP/SP-Piezo2 findings into practical assay-design decisions without overstating cross-domain evidence.

774 records 4/52 page Previous Next 12345 下5页 Last page